Page last updated: 2024-11-01

nitroglycerin and Androgen-Independent Prostatic Cancer

nitroglycerin has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouaouiche, S1
Magadoux, L1
Dondaine, L1
Reveneau, S1
Isambert, N1
Bettaieb, A1
Jeannin, JF1
Laurens, V1
Plenchette, S1

Other Studies

1 other study available for nitroglycerin and Androgen-Independent Prostatic Cancer

ArticleYear
Glyceryl trinitrate‑induced cytotoxicity of docetaxel‑resistant prostatic cancer cells is associated with differential regulation of clusterin.
    International journal of oncology, 2019, Volume: 54, Issue:4

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clusterin; Docetaxel; Drug Resistance,

2019